ClinicalTrials.Veeva

Menu

Integration of Cryobiopsies for ILD Diagnoses- Experience Based on 250 Biopsy Procedures.

A

Aarhus University Hospital

Status

Completed

Conditions

Interstitial Lung Disease

Study type

Observational

Funder types

Other

Identifiers

NCT05311345
Cryobiopsy 250

Details and patient eligibility

About

A retrospective study on safety and Diagnostic yield in using cryobiopsies as a Diagnostic tool in diagnosing patients under investigation for Interstitial lung diseases. This includes a registration of procedural techniques, complications ( pneumthorax, hemorrhage, exacerbation and mortalt), days admitted at the hospital, diagnoses and diagnostic yield.

Enrollment

250 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • >18years of age
  • suspected of Interstitial lung Disease
  • cryobiopsies performed.

Exclusion criteria

  • FVC below 50% of predicted
  • DLCO below 35%
  • Body Mass Index (BMI) above 35
  • pulmonary hypertension with a tricuspidal gradient above 40 mmHg
  • other cardiac or other comorbidities that would increase the risk of complications

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems